Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Experiment Videos

Testing secondary hypotheses following sequential clinical trials.

A Liu1, M Tan, J M Boyett

  • 1Biostatistics Unit, Lombardi Cancer Center, Georgetown University Medical Center, Washington, DC 20007, USA. Liua1@gunet.georgetown.edu

Biometrics
|July 6, 2000
PubMed
Summary
This summary is machine-generated.

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Black Hole Spectroscopy and Tests of General Relativity with GW250114.

Physical review letters·2026
Same author

The Ruminant Farm Systems (RuFaS) model is a platform to support future research and actions for sustainable dairy farming.

JDS communications·2026
Same author

Radiomic signatures to estimate survival in patients with advanced hepatocellular carcinoma treated with sorafenib: Cancer and Leukemia Group B 80802 (Alliance).

ESMO open·2025
Same author

Adverse events associated with sequential immune checkpoint inhibitor and alectinib in patients with ALK-rearranged advanced non-small-cell lung cancer.

ESMO open·2025
Same author

GW250114: Testing Hawking's Area Law and the Kerr Nature of Black Holes.

Physical review letters·2025
Same author

Unifying measurement schemes in 2D terahertz spectroscopy.

The Journal of chemical physics·2025

Sequential monitoring in clinical trials complicates hypothesis testing for secondary endpoints. This study enhances conventional methods, improving statistical power while controlling Type I errors for more reliable trial results.

Area of Science:

  • Clinical Trials
  • Biostatistics
  • Statistical Inference

Background:

  • Sequential monitoring in clinical trials presents challenges for hypothesis testing on secondary endpoints post-termination.
  • Conventional likelihood-based testing procedures that disregard sequential monitoring can inflate Type I errors and reduce statistical power.

Purpose of the Study:

  • To address the limitations of conventional testing procedures in sequentially monitored clinical trials.
  • To propose a method that improves statistical power while maintaining controlled Type I error rates for secondary endpoints.

Main Methods:

  • The study develops and illustrates a novel statistical testing procedure designed for sequentially monitored clinical trials.
  • The proposed method aims to correct for the inflation of Type I error and the reduction in power associated with standard approaches.

Related Experiment Videos

Main Results:

  • The proposed method demonstrates substantial improvement in statistical power compared to conventional procedures.
  • Type I error rates are effectively controlled, ensuring the reliability of the hypothesis testing outcomes.
  • The efficacy of the method was validated using data from a real-world clinical trial.

Conclusions:

  • The developed statistical approach offers a significant advancement for hypothesis testing on secondary endpoints in sequentially monitored clinical trials.
  • This method provides a more powerful and reliable alternative to conventional procedures, enhancing the interpretation of trial results.